Literature DB >> 11861665

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

Jill Rubin1, Furcy Paultre, Catherine H Tuck, Steve Holleran, Roberta G Reed, Thomas A Pearson, Christopher M Thomas, Rajasekhar Ramakrishnan, Lars Berglund.   

Abstract

Plasma lipoprotein [a] (Lp[a]) concentrations are inversely associated with, and largely determined by, apolipoprotein [a] (apo[a]) gene size, a highly polymorphic trait. We studied if, within an individual, the smaller apo[a] isoform always dominated, whether there was interaction between the two alleles, and whether these features differed between Caucasians and African Americans. We determined apo[a] gene sizes, apo[a] protein sizes and relative amounts, and plasma Lp[a] levels in 430 individuals (263 Caucasians and 167 African Americans). Of the 397 heterozygotes with at least one detectable apo[a] isoform (238 Caucasians and 159 African Americans), the larger allele dominated in 28% of Caucasians and 23% of African Americans, while the smaller allele dominated in 56% of Caucasians and 45% of African Americans. In Caucasians, dominance of the smaller allele increased with Lp[a] levels, from 44% at Lp[a] < or = 30 nM to 81% at Lp[a] >100 nM (P < 0.0001). Dominance by the smaller allele increased with increasing size of the larger allele in both groups but with the smaller allele only in African Americans. There was no interaction between apo[a] alleles within genotypes; one apo[a] isoform level was not associated with the other isoform level, and isoform levels were not affected by the difference in size. More of the dominance pattern was explained by Lp[a] level and apo[a] genotype in African Americans than in Caucasians (29% vs. 13%). Thus, genotype influences isoform-specific Lp[a] levels and dominance patterns differently in African Americans and in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861665

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Zeynep Ozturk; Wei Zhang; Thomas A Pearson; Lars Berglund
Journal:  Transl Res       Date:  2011-02-05       Impact factor: 7.012

3.  Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Lars Berglund
Journal:  Atherosclerosis       Date:  2014-05-10       Impact factor: 5.162

4.  Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Thomas A Pearson; Lars Berglund
Journal:  Atherosclerosis       Date:  2010-04-20       Impact factor: 5.162

5.  Rhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms.

Authors:  Byambaa Enkhmaa; Adnan Abbuthalha; Erdembileg Anuurad; Wei Zhang; Alice F Tarantal; Lars Berglund
Journal:  J Med Primatol       Date:  2015-02-12       Impact factor: 0.667

Review 6.  Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Tina Tran; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2011-07-12       Impact factor: 1.894

7.  Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Kyoungmi Kim; Lars Berglund
Journal:  J Lipid Res       Date:  2019-07-18       Impact factor: 5.922

Review 8.  Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.

Authors:  Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

Review 9.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

10.  HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Adnan Abbuthalha; Xiao-Dong Li; William Dotterweich; Richard B Pollard; David M Asmuth; Lars Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-29       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.